Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).

doi:10.1007/s13730-018-0331-4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).

CEN case reports - 1 Nov 2018

Sasaki Masaru, Yasuno Tetsuhiko, Ito Kenji, Matsunaga Akira, Hisano Satoshi, Abe Yasuhiro, Miyake Katsuhisa, Masutani Kosuke, Nakashima Hitoshi, Saito Takao

Abstract excerpt

Apolipoprotein (apo) E5 is a rare apoE isoform. The apoE5 (Glu3Lys) variant, which is caused by the substitution of lysine with glutamic acid at codon 3, has a relative frequency of 0.1% in Japan. Previous studies have reported that apoE5 (Glu3Lys) is associated with hyperlipidemia and cardiovascular diseases, but this isoform has higher LDL receptor-binding activity than that of normal apoE3. Nephropathy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin Receptor Antagonists
Share to Foam Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glomerulosclerosis, Focal Segmental

Share to Hypertrophy

Share to Kidney Glomerulus

Share to Monoclonal Gammopathy of Undetermined Significance

Share to Podocytes

Share to Sclerosis

Source

Open in PubMed Open full text

Identifiers

PMID: 29740794
DOI: 10.1007/s13730-018-0331-4
PMCID: PMC6181881

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.